Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.
| Revenue (TTM) | $2.84B |
| Gross Profit (TTM) | $1.94B |
| EBITDA | $1.78B |
| Operating Margin | 17.30% |
| Return on Equity | -4.08% |
| Return on Assets | 0.93% |
| Revenue/Share (TTM) | $16.66 |
| Book Value | $91.10 |
| Price-to-Book | 0.53 |
| Price-to-Sales (TTM) | 2.84 |
| EV/Revenue | 7.6 |
| EV/EBITDA | 30.51 |
| Quarterly Earnings Growth (YoY) | 648.00% |
| Quarterly Revenue Growth (YoY) | -11.90% |
| Shares Outstanding | $172.09M |
| Float | $154.66M |
| % Insiders | 1.38% |
| % Institutions | 99.48% |
Volatility is currently expanding
Alexandria Real Estate Equities is mispriced as a distressed office REIT, offering a 'Strong Buy' opportunity. ARE's specialized life sciences campuses in top biotech hubs anchor high-quality tenants and provide a unique competitive moat. At a 50% discount to intrinsic value, ARE offers a 5.9% secure dividend yield and a robust balance sheet with $3.6 billion in liquidity.
Alexandria Real Estate Equities, Inc. (ARE) Q2 2026 Earnings Call Transcript
Alexandria Real Estate Equities NYSE: ARE reported second-quarter 2026 adjusted funds from operations of $1.73 per diluted share and reaffirmed the midpoint of its full-year guidance at $6.40 per share, while narrowing the annual range to plus or minus $0.05.
Alexandria's Q2 FFO beat estimates as leasing tops 1 million RSF, rental-rate declines ease and 1.4 million RSF awaits lease commencement.
Alexandria Real Estate is showing clear signs of fundamental recovery, with Q2 results and Q3 guidance exceeding expectations. Leasing momentum is accelerating, highlighted by a 60% QoQ increase in leasing volumes and strong tenant retention, signaling a flight to quality. Capital recycling is focused on monetizing non-core assets, especially land, to protect core cash-generating properties and strengthen the balance sheet.
While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PASADENA, Calif., Aug. 3, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the second quarter ended June 30, 2026.
Investors need to pay close attention to ARE stock based on the movements in the options market lately.
PASADENA, Calif, July 29, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation clusters, today announced with the Foundation for the National Institutes of Health (FNIH) that the Multi-Modal Assessment and Phenotyping in Depression (MAP-D) initiative has successfully completed its critical design phase, marking a foundational milestone toward a first-of-its-kind clinical study designed to redefine how major depressive disorder is diagnosed and treated through precision medicine. Launched with Alexandria's vision and first funding, and founded on its strategic partnership with the FNIH, MAP-D seeks to identify and validate biological signatures of depression that can enable more personalized treatment approaches, accelerate the development of more effective therapies and ultimately improve outcomes for millions of patients.
ARE's Q2 results are likely to face pressure from lower occupancy, lease expirations and weaker same-property revenues.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARE and any ticker you trade — then tracks every position and per-strategy win rate.
